Sep 14, 2023 / 01:00PM GMT
Timothy Power - Bristol-Myers Squibb Company - VP & Head of IR
Well, good morning. I'm Tim Power. I'm Head of Investor Relations here at BMS. I just really want to welcome you to our R&D Day this morning. We are really thrilled to have you with us today. We've got a lot to go through, and we're going to show a lot of the progress we've been making on our pipeline and our research.
Our next slide is our legal slide. But if I go to the agenda, you can see we really do have a lot to cover this morning. And you're going to hear today from 3 members of our leadership team, from Chris Boerner, our Chief Operating Officer and incoming CEO. You'll hear from Robert Plenge, our Head of Early Research, and from Samit Hirawat, who runs Global Drug Development.
Now beyond those, we have many members of our management team with us today, including Giovanni Caforio, our Board Chair and Chief Executive Officer. Also from our leadership team, we have David Elkins, our CFO; Adam Lenkowsky, our Chief Commercialization Officer. I know you know both David and Adam well as well. And we have many
Bristol-Myers Squibb Co R&D Day Transcript
Sep 14, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers